79292215 - MODAG

Information

• Trademark
• 79292215

• Source

• Serial Number

  79292215

• Registration Number

  6422358

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 31, 2020
  4 years ago

• Registration Date

  July 20, 2021
  3 years ago

• Transaction Date

  October 11, 2024
  2 months ago

• Status Date

  July 20, 2021
  3 years ago

• Published for Opposition Date

  May 04, 2021
  3 years ago

• Location Date

  July 20, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CHUO, EMILY

• Attorney Name

  Catherine F. Hoffman

  Law Office Assigned Location Code

  L10

• Owners

  • MODAG GmbH

Case File Statements

• DM0000: The mark consists of the wording "MODAG" in a stylized font where the letters "M", "D", "A" and "G" are in dark blue, the letter "O" is grey, and the letters "O" and "G" encircle a green dot.
• CD0000: The letters M, D, A and G are dark blue, the letter O is grey and the letters O and G encircle a green dot.
• GS0051: Pharmaceutical drugs and medicines for the treatment of the nervous system and for the treatment of diseases characterized by pathological protein aggregation; diagnostic preparations for medical purposes
• CC0000: The color(s) dark blue, green and grey is/are claimed as a feature of the mark.
• GS0011: Chemical substances, chemical materials, chemical compositions and chemical preparations, all of the foregoing for use in science
• GS0441: Medical services in the field of diseases characterized by pathological protein aggregation; Medical diagnosis of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; medical services in the field of neurodegenerative diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis, prognosis and treatment of neurodegenerative diseases and diseases characterized by pathological protein aggregation; providing medical data and information in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation to healthcare professionals; rental of medical apparatus and equipment, and fittings therefor
• GS0101: Medical apparatus and instruments for monitoring molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor; Medical diagnostic apparatus for testing molecular biomarkers of neurodegenerative diseases and diseases characterized by pathological protein aggregation such as pathologically modified and/or pathologically aggregated proteins and parts and fittings therefor
• GS0421: Scientific and technological services, namely, research and design in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; industrial analysis and research services in the field of neurodegenerative diseases and diseases characterized by pathological protein aggregation; biological research; research and development of new products for others; Conducting clinical trials for others in the field of nervous system diseases such as neurodegenerative diseases and diseases characterized by pathological protein aggregation; Scientific laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; pharmaceutical drug development services

Case File Event Statements

• 9/25/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/19/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/20/2020 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 8/21/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/21/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/21/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/22/2020 - 4 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/25/2020 - 4 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/25/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/22/2021 - 3 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/23/2021 - 3 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/31/2021 - 3 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/22/2021 - 3 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/14/2021 - 3 years ago

  15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/14/2021 - 3 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/4/2021 - 3 years ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/14/2021 - 3 years ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/2/2021 - 3 years ago

  17 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/4/2021 - 3 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/20/2021 - 3 years ago

  20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/26/2024 - 10 months ago

  25 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 10/20/2021 - 3 years ago

  21 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 12/1/2021 - 3 years ago

  22 - FINAL DISPOSITION PROCESSED Type: FIMP

• 12/1/2021 - 3 years ago

  23 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 12/19/2021 - 3 years ago

  24 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 2/26/2024 - 10 months ago

  26 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/26/2024 - 10 months ago

  27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 2/26/2024 - 10 months ago

  28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 2/26/2024 - 10 months ago

  29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/11/2024 - 2 months ago

  30 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP